IceCure Medical (ICCM) vs Phaos Technology (Cayman) (POAS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
IceCure Medical is the larger company by market cap ($5.1 million vs $4.4 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ICCM | POAS |
|---|---|---|
| Share price | $1.10 | $0.138 |
| Market cap | $5.10M | $4.36M |
| 1-day change | -3.08% | -2.82% |
| EPS (TTM) | $-6.63 | $-0.38 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $29.46 | $7.40 |
| 52-week low | $1.04 | $0.132 |
| Distance from 52-week high | -96.27% | -98.13% |
| Analyst consensus | none | — |
| Avg. price target upside | +1960.91% | — |
| Average volume | 139.24K | 239.81K |
| Shares outstanding | 4.64M | 16.45M |
| Employees | 67 | 10 |
| Sector | Health Care | Industrials |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: IceCure Medical in Health Care and Phaos Technology (Cayman) in Industrials.
About IceCure Medical
ICCM stock →IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.
Health Care · Medical/Dental Instruments · 67 employees
About Phaos Technology (Cayman)
POAS stock →Phaos Technology Holdings (Cayman) Limited, through its subsidiary, Phaos Technology Pte. Ltd., engages in the manufacturing and commercialization of advanced microscopy-related solutions, technologies, and products in Singapore.
Industrials · Industrial Machinery/Components · 10 employees
ICCM vs POAS FAQ
Which is bigger, IceCure Medical or Phaos Technology (Cayman)?
IceCure Medical (ICCM) is larger, with a market capitalization of $5.10M compared with $4.36M for Phaos Technology (Cayman) (POAS).
Are IceCure Medical and Phaos Technology (Cayman) in the same industry?
No. IceCure Medical is in the Health Care sector, while Phaos Technology (Cayman) is in Industrials.